Memantine for the treatment of mild and mild-to-moderate...

Details Memantine for the treatment of mild and mild-to-moderate... Memantine for the treatment of mild and mild-to-moderate...

A - Human Necessities

61

K

A61K 31/13 (2006.01) A61K 45/06 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2551689

The present invention provides a method for the treatment, prevention, or delay of progression of mild, or mild-to-moderate Alzheimer's disease, by administering an effective dose of memantine. The present invention also provides a method for preventing the decrease in glucose metabolism in the cortical and sub-cortical regions of the brain in subjectes with mild, or mild- to-moderate Alzheimer's disease.

L'invention concerne un procédé destiné à traiter, prévenir, ou retarder la progression de la maladie d'Alzheimer légère, ou légère à modérée, par administration d'une dose efficace de mémantine. Cette invention concerne également un procédé destiné à empêcher la baisse du métabolisme glucosique dans les zones corticales et sous-corticales du cerveau chez des sujets souffrant de la maladie d'Alzheimer légère, ou légère à modérée.

Affiliated with

Also associated with

Rating

Memantine for the treatment of mild and mild-to-moderate... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Memantine for the treatment of mild and mild-to-moderate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Memantine for the treatment of mild and mild-to-moderate... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2088496